share_log

Truist Securities Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $40

Truist Securities Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $40

信託證券維持對Collegium Pharmaceutical的買入,將目標股價上調至40美元
Moomoo 24/7 ·  02/26 08:20

Truist Securities analyst Les Sulewski maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $37 to $40.

Truist Securities分析師萊斯·蘇萊夫斯基維持Collegium Pharmaceutical(納斯達克股票代碼:COLL)的買入並將目標股價從37美元上調至40美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論